An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera

Journal of Virological Methods

Volumn 210, Issue , 2014, Pages 7-14

  Couzens, Laura ^a   Gao, Jin ^a   Westgeest, Kim ^b   Sandbulte, Matthew ^a   Lugovtsev, Vladimir ^a   Fouchier, Ron ^b   Eichelberger, Maryna ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antibody; Enzyme linked lectin assay; Influenza; Neuraminidase; Serology

Indexed keywords

THIOBARBITURIC ACID; VIRUS SIALIDASE; INFLUENZA VACCINE; LECTIN; SIALIDASE; THIOBARBITURIC ACID DERIVATIVE; VIRAL PROTEIN; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED LECTIN ASSAY; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS A H6N1; INFLUENZA VIRUS A H6N2; INTERMETHOD COMPARISON; MEASUREMENT PRECISION; NONHUMAN; NORMAL HUMAN; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS INHIBITION; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY PRODUCTION; BLOOD; COMPARATIVE STUDY; CROSS REACTION; ENZYME IMMUNOASSAY; ENZYMOLOGY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS; MUSTELA PUTORIUS FURO; SIGMODONTINAE; VALIDATION STUDY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CROSS REACTIONS; FERRETS; HUMANS; IMMUNOENZYME TECHNIQUES; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LECTINS; NEURAMINIDASE; SIGMODONTINAE; THIOBARBITURATES; VIRAL PROTEINS;

EID: 84908173790     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.09.003     Document Type: Article

References (26)

1. Anders E.M., Hartley C.A., Jackson D.C. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4485-4489.
2. Bland J.M., Altman D.G. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 1999, 8:135-160.
3. Cate T.R., Rayford Y., Nino D., Winokur P., Brady R., Belshe R., Chen W., Atmar R.L., Couch R.B. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine 2010, 28:2076-2079.
4. Clements M.L., Betts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 1986, 24:157-160.
5. Compans R.W., Dimmock N.J., Meier-Ewert H. Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus. J. Virol. 1969, 4:528-534.
6. Couch R.B., Atmar R.L., Franco L.M., Quarles J.M., Wells J., Arden N., Nino D., Belmont J.W. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J. Infect. Dis. 2013, 207:974-981.
7. Couch R.B., Atmar R.L., Keitel W.A., Quarles J.M., Wells J., Arden N., Nino D. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine 2012, 31:190-195.
8. Eichelberger M., Rivers K., Ream R., Gao J., Hassantoufighi A., Straight T.M. Qualitative differences in T cell responses to live, attenuated and inactivated influenza vaccines. J. Clin. Cell. Immunol. 2011, S4:8.
9. Fries L.F., Smith G.E., Glenn G.M. A recombinant viruslike particle influenza A (H7N9) vaccine. N. Engl. J. Med. 2013, 369:2564-2566.
10. Fritz R., Sabarth N., Kiermayr S., Hohenadl C., Howard M.K., Ilk R., Kistner O., Ehrlich H.J., Barrett P.N., Kreil T.R. A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies. J. Infect. Dis. 2012, 205:28-34.
11. Hartshorn K.L., Sastry K., Brown D., White M.R., Okarma T.B., Lee Y.M., Tauber A.I. Conglutinin acts as an opsonin for influenza A viruses. J. Immunol. 1993, 151:6265-6273.
12. Hassantoufighi A., Zhang H., Sandbulte M., Gao J., Manischewitz J., King L., Golding H., Straight T.M., Eichelberger M.C. A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses. Vaccine 2010, 28:790-797.
13. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6108-6113.
14. Job E.R., Bottazzi B., Gilbertson B., Edenborough K.M., Brown L.E., Mantovani A., Brooks A.G., Reading P.C. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLOS ONE 2013, 8:e59623.
15. Johansson B.E., Kilbourne E.D. Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J. Virol. 1993, 67:5721-5723.
16. Johansson B.E., Kilbourne E.D. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology 1996, 225:136-144.
17. Kilbourne E.D., Johansson B.E., Grajower B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:786-790.
18. Kilbourne E.D., Laver W.G., Schulman J.L., Webster R.G. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J. Virol. 1968, 2:281-288.
19. Lambre C.R., Terzidis H., Greffard A., Webster R.G. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J. Immunol. Methods 1990, 135:49-57.
20. Matrosovich M., Gao P., Kawaoka Y. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host. J. Virol. 1998, 72:6373-6380.
21. Murphy B.R., Kasel J.A., Chanock R.M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N. Engl. J. Med. 1972, 286:1329-1332.
22. Rogers G.N., Pritchett T.J., Lane J.L., Paulson J.C. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology 1983, 131:394-408.
23. Sandbulte M.R., Gao J., Straight T.M., Eichelberger M.C. A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens. Influenza Other Respir Viruses 2009, 3:233-240.
24. Sandbulte M.R., Westgeest K.B., Gao J., Xu X., Klimov A.I., Russell C.A., Burke D.F., Smith D.J., Fouchier R.A., Eichelberger M.C. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20748-20753.
25. Sultana I., Gao J., Markoff L., Eichelberger M.C. Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir. Vaccine 2011, 29:2601-2606.
26. White M.R., Crouch E., van Eijk M., Hartshorn M., Pemberton L., Tornoe I., Holmskov U., Hartshorn K.L. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L831-L840.